BEONE MEDICINES LTD. (ONC) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 2.12B USD | Liabilities, Current |
| Cash and equivalents | 5.10B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 1.06B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 732.60M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $2.12B | $5.10B | (m) | $1.06B | $732.60M | (m) |
| 2026-03-31 | (m) | $1.81B | $4.79B | (m) | $938.02M | $681.59M | (m) |
| 2025-12-31 | (m) | $1.83B | $4.55B | (m) | $865.08M | $608.23M | (m) |
| 2025-09-30 | (m) | $2.37B | $4.04B | (m) | $863.28M | $531.69M | (m) |
| 2025-06-30 | (m) | $2.21B | $2.76B | (m) | $770.78M | $502.87M | (m) |
| 2025-03-31 | (m) | $1.98B | $2.52B | (m) | $717.24M | $494.66M | (m) |
| 2024-12-31 | (m) | $2.21B | $2.63B | (m) | $676.28M | $494.99M | (m) |
| 2024-09-30 | (m) | $2.03B | $2.70B | (m) | $569.05M | $431.68M | (m) |
| 2024-06-30 | (m) | $1.94B | $2.59B | (m) | $529.45M | $443.26M | (m) |
| 2024-03-31 | (m) | $1.88B | $2.79B | (m) | $435.29M | $447.35M | (m) |
| 2023-12-31 | (m) | $1.81B | $3.17B | (m) | $358.03M | $416.12M | (m) |
| 2023-09-30 | (m) | $1.28B | $3.07B | (m) | $309.08M | $316.93M | (m) |
| 2023-06-30 | (m) | $1.41B | $3.41B | (m) | $299.28M | $321.33M | (m) |
| 2023-03-31 | (m) | $1.25B | $3.54B | (m) | $309.63M | $297.00M | (m) |
| 2022-12-31 | (m) | $1.47B | $3.87B | (m) | $173.17M | $282.35M | (m) |
| 2022-09-30 | (m) | $1.41B | $4.20B | (m) | $189.17M | $290.91M | (m) |
| 2022-06-30 | (m) | $1.40B | $4.53B | (m) | $172.26M | $262.21M | (m) |
| 2022-03-31 | $6.44B | $1.38B | $4.35B | $1.90B | $190.80M | $245.63M | 4.68× |
| 2021-12-31 | $7.10B | $1.60B | $4.38B | $2.24B | $483.11M | $242.63M | 4.44× |
| 2021-09-30 | $4.05B | $1.30B | $1.38B | $2.53B | $129.58M | $150.98M | 3.10× |
| 2021-06-30 | $4.46B | $1.24B | $1.78B | $2.61B | $73.79M | $117.59M | 3.59× |
| 2021-03-31 | $4.90B | $1.11B | $1.90B | $2.91B | $84.01M | $72.97M | 4.40× |
| 2020-12-31 | $4.71B | $1.08B | $1.38B | $3.27B | $60.40M | $89.29M | 4.38× |
| 2020-09-30 | $4.78B | $645.72M | $1.46B | $3.25B | $60.27M | $35.52M | 7.40× |
| 2020-06-30 | $3.21B | $551.20M | $1.35B | $1.81B | $61.66M | $33.23M | 5.83× |
| 2020-03-31 | $3.44B | $451.80M | $1.96B | $1.42B | $65.62M | $28.77M | 7.61× |
| 2019-12-31 | $1.05B | $310.31M | $618.01M | $364.73M | $70.88M | $28.55M | 3.40× |
| 2019-09-30 | (m) | $265.73M | $856.15M | (m) | $55.91M | $37.51M | (m) |
| 2019-06-30 | (m) | $271.68M | $918.95M | (m) | $58.11M | $49.05M | (m) |
| 2019-03-31 | (m) | $238.81M | $764.49M | (m) | $58.98M | $13.14M | (m) |
| 2018-12-31 | (m) | $246.45M | $712.94M | (m) | $41.06M | $16.24M | (m) |
| 2018-09-30 | (m) | $188.42M | $643.49M | (m) | $37.37M | $19.70M | (m) |
| 2018-06-30 | (m) | $186.44M | $438.42M | (m) | $33.17M | $6.32M | (m) |
| 2018-03-31 | (m) | $141.90M | $490.63M | (m) | $23.48M | $7.50M | (m) |
| 2017-12-31 | (m) | $149.99M | $239.60M | (m) | $29.43M | $10.93M | (m) |
| 2017-09-30 | $717.89M | $103.16M | $208.51M | $498.86M | $10.52M | $5.71M | 6.96× |
| 2017-06-30 | (m) | $49.95M | $261.01M | $146.42M | (m) | (m) | (m) |
| 2017-03-31 | (m) | $49.98M | $97.75M | $229.73M | (m) | (m) | (m) |
| 2016-12-31 | (m) | $35.06M | $87.51M | $280.66M | (m) | (m) | (m) |
| 2016-09-30 | (m) | $29.32M | $85.53M | $118.09M | (m) | (m) | (m) |
| 2016-06-30 | (m) | $20.46M | $58.08M | $168.53M | (m) | (m) | (m) |
| 2016-03-31 | (m) | $15.83M | $208.51M | $38.72M | (m) | (m) | (m) |
| 2015-12-31 | (m) | $35.17M | $17.87M | $82.62M | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | $27.45M | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | $25.16M | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | $13.37M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | $13.90M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | $3.93M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.